I. Review Procedure
On March 30, 2026, Kanglong Chemical (Beijing) Co., Ltd. (hereinafter referred to as "the Company") held the 19th meeting of the 3rd Board of Directors, where the proposal on the profit distribution plan for 2025 and the mid-term dividend plan for 2026 was approved. This matter is subject to review by the Company's shareholders' meeting.
II. Basic Situation of Profit Distribution
According to the audit conducted by a domestic accounting firm, the net profit attributable to shareholders of the listed company for 2025 under Chinese accounting standards is RMB 1,663,898,879.44, while the net profit of the parent company is RMB 4,098,999,318.89. As of December 31, 2025, the cumulative statutory surplus reserve of the Company has reached 50% of the registered capital, and according to the Company Law of the People's Republic of China and relevant regulations, no further allocation is required. The actual provision for this period is RMB 75,206,014.71. As of December 31, 2025, the cumulative distributable profits in the parent company’s financial statements amount to RMB 9,503,113,930.38; in the consolidated financial statements, the cumulative distributable profits amount to RMB 7,678,758,290.34. Based on the lower of the two, the cumulative distributable profits for this year are RMB 7,678,758,290.34.